Fact CheckerSign in

NCT04094038Active, not recruitingPhase 4

The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients

Source: ClinicalTrials.gov · Last updated 12 Feb 2026

Brief summary (registry, in English)

Protein-energy wasting (PEW), a hypercatabolic state characterized by loss of muscle mass and fuel reserves, is highly prevalent in hemodialysis patients. Nutritional status and body composition are closely linked to morbidity, mortality and quality of life. Lean tissue mass (LTM) appears to be the best read-out for the association between nutritional status and outcomes. Intradialytic parenteral nutrition (IDPN) is occasionally used with the aim to reduce loss of LTM, but its efficacy has not been established. The goal of this study is to study the effect of IDPN on changes in LTM in hemodialysis patients.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
166 (estimated)
First submitted
12 Sept 2019
Start date
16 Sept 2019
Primary completion date
2 Apr 2024
Lead sponsor
Erasmus Medical Center
NCT number
NCT04094038
EudraCT number
2018-003899-13

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 166
  • From 16 Sept 2019 to the primary completion date, 2 Apr 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Planned kidney transplant within 4 months
  • Parenteral nutrition within four weeks prior to screening

Other illness

  • Severe overhydration leading to respiratory insufficiency
  • Severe hepatic insufficiency
  • Active treatment for infection
  • Acute myocardial infarction
  • Hypersensitivity for any Olimel N12 ingredient or excipient

Other

  • Life expectancy \< 6 months
  • Pregnancy
  • Unipolar pacemaker with a very low sensitivity threshold
  • Circulatory shock

Who the study is looking for

  • Undergoing chronic hemodialysis

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Erasmus MC
Coordinator of this site? Confirm its status
RotterdamNetherlandsUnknown status
Franciscus Gasthuis & Vlietland
Coordinator of this site? Confirm its status
RotterdamNetherlandsUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.